Davis Polk & Wardwell and Jia Yuan Law Offices have advised Chinese clinical trial and research firm Hangzhou Tigermed Consulting on its $1.38 billion Hong Kong IPO, with Freshfields Bruckhaus Deringer and Zhong Lun Law Firm representing the sponsors.

Tigermed, which is already listed in Shenzhen, is the largest clinical research trial provider in mainland China. According to Reuters, Tigermed will sell 107.06 million shares in this IPO, which could make the deal the largest healthcare transaction in Asia this year, topping WuXi Biologics’ $984 million share placement in May.

The Jia Yuan Law Offices team advising on the deal was led by partners Wang Yuan and Fu Yangyuan.

Meanwhile, partners Zhang Jinquan, Zhu Ying, Zhong Yang and Li Xiang led the Zhong Lun Law Firm team.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com.

Related Articles

Features

BRIEF: Malaysia Offers Investors Cooling IPO Respite During Sluggish Summer

by Sarah Wong |

In a year when global IPO markets have wilted under the economic heat, Bursa Malaysia has stood out as a surprising oasis of activity.

Deals

JSA, Trilegal act on NTPC Green’s upcoming $1.2bln IPO

by Nimitt Dixit |

JSA Advocates & Solicitors is advising NTPC Green Energy, state-run power producer National Thermal Power Corporation’s renewable energy arm, on its announced initial public offering worth $1.2 billion, with Trilegal advising the book running lead managers.

Deals

CAM, Khaitan, Links act on Bajaj Housing Finance’s $782mln IPO

by Nimitt Dixit |

Cyril Amarchand Mangaldas has advised Indian home-loan financier Bajaj Housing Finance (BHF) and its promoter Bajaj Finance on BHF’s $782 million initial public offering, with Khaitan & Co and Linklaters representing the book-running lead managers to the offer.